AC
BIIB icon

AXQ Capital’s Biogen BIIB Stock Holding History

AXQ Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,556
Closed -$302K – 442
2024
Q3 		$302K Buy
+1,556
New +$326K 0.09% 339
2024
Q2 		– Sell
-1,800
Closed -$388K – 471
2024
Q1 		$388K Sell
1,800
-1,100
-38% -$258K 0.09% 371
2023
Q4 		$750K Sell
2,900
-900
-24% -$221K 0.2% 180
2023
Q3 		$977K Buy
+3,800
New +$1.02M 0.34% 94

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AXQ Capital's BIIB Position: Q4 2024 in Review

AXQ Capital sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,556 shares — an estimated $302K sold.

AXQ Capital first reported a position in BIIB in Q3 2023 and held it in 4 quarters. The position peaked at $977K in Q3 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • AXQ Capital reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • AXQ Capital sold 1,556 Biogen shares in Q4 2024, an estimated $302K.
  • AXQ Capital first reported a position in Biogen in Q3 2023 and held it in 4 quarters.
  • AXQ Capital's Biogen position peaked at $977K in Q3 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on AXQ Capital's 13F filing for Q4 2024, filed 11 Feb 2025.